Shares of Zydus Lifesciences hit a 52-week high of Rs 680 on 18 December after the company announced receiving final approval from the USFDA (United...
Zydus Lifesciences, on 15 December, announced that it had received approval from the USFDA (US Food and Drug Administration) to market a generic antiviral medication...
Shares of Zydus Lifescience were trading in the green and 1% higher on 6 December after the company’s US subsidiary, Sentynl Therapeutics, assumed full responsibility...
Shares of Zydus Lifesciences, on 6 December, announced that it had received final approval from the USFDA (United States Food and Drug Administration) for manufacturing...
Zydus Lifesciences, on 1 December, announced that it had received final approval from the USFDA (United States Food and Drug Administration) for its tablets that...
Shares of Zydus Lifesciences were trading 3% higher on 7 November after the company announced its earnings for the July-September quarter of the current fiscal...
Indian Pharmaceutical major Zydus Lifesciences, on 31 October, announced that its board had approved the acquisition of LiqMeds for Rs 689 crore. The company is...
Zydus Lifesciences shares were trading marginally above on 23 October after the company announced receiving approval from USFDA (the United States Food and Drug Administration)...
Zydus Lifesciences Limited on 6 October announced that it had received the final approval from the USFDA (the United States Food and Drug Administration) for...
Zydus Lifesciences on 21 September announced that it had received final approval from the USFDA (United States Food and Drug Administration) for a skin-care gel...